Protaryx Medical announced that it received FDA 510(k) clearance for its proprietary Transseptal Puncture Device.

Device-based left atrial appendage (LAA) closure was comparable to non-vitamin K antagonist oral anticoagulant (NOAC) therapy in reducing the combined rate of death from cardiovascular causes, stroke, ...

MARLBOROUGH, Mass. and NEW ORLEANS, March 28, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that the CHAMPION-AF global clinical trial met all primary and secondary ...

Data highlights the WATCHMAN FLX device provided statistically superior protection from bleeding, demonstrated similar efficacy compared to blood thinners in patients with non-valvular atrial ...

For patients with atrial fibrillation, the use of oral anticoagulant therapy to prevent stroke is limited by the risk of bleeding. Left atrial appendage closure is considered for patients who are ...

TCTMD reported in-depth on the CLOSURE-AF trial after its November 8, 2025, presentation at the AHA Scientific Sessions. The study has now been published in the New England Journal of Medicine. NEW ...

Three Successful First-in-Human Cases Completed in El Salvador Company to Exhibit at SAGES 2026 Annual Meeting in Tampa MISGAV, Israel, March 16, 2026 /PRNewswire/ -- Seger Surgical Solutions Ltd.

ABSTRACT: Simultaneous presentation of ST-elevation myocardial infarction (STEMI) and pulmonary embolism (PE) is rare and should prompt consideration of paradoxical embolism (PDE) through a patent ...

ABSTRACT: Simultaneous presentation of ST-elevation myocardial infarction (STEMI) and pulmonary embolism (PE) is rare and should prompt consideration of paradoxical embolism (PDE) through a patent ...

“Where a claim lists limitations separately, the clear implication of the claim language is that those elements are distinct components in the patented invention.” – CAFC The U.S. Court of Appeals for ...

BOSTON, March 4, 2026 /PRNewswire/ -- Intrinsic Therapeutics, Inc. has introduced the Barricaid ® Narrow Anchor, the next generation of its FDA PMA-approved Barricaid ® Bone-Anchored Annular Closure ...